Enzyme Inactivation and Degradation

Enzyme inactivation and degradation are the processes by which a cell ends an enzyme's activity, either by loss of its functional state or by its physical destruction. Together with synthesis, regulated degradation sets the steady-state amount of each enzyme and provides a slower but decisive layer of control beyond reversible inhibition.

Definition

Enzyme inactivation is the loss of an enzyme's catalytic function through denaturation, covalent modification, or damage; enzyme degradation is the regulated proteolytic destruction of the enzyme protein, which lowers its cellular concentration.

Scope

The entry covers loss of activity through denaturation and covalent modification, and the regulated turnover of enzymes by intracellular proteolytic systems, principally the ubiquitin-proteasome pathway. It is a biochemical reference, not clinical guidance.

Core questions

• What distinguishes loss of activity (inactivation) from physical destruction (degradation)?
• How does the cell selectively mark specific enzymes for degradation?
• How does regulated turnover set the amount of an enzyme present at steady state?

Key concepts

• Inactivation vs degradation
• Denaturation and covalent damage
• Ubiquitin tagging
• 26S proteasome
• Enzyme half-life and turnover
• Steady-state enzyme concentration

Key theories

Ubiquitin-proteasome system of selective degradation

Proteins destined for destruction are covalently tagged with chains of ubiquitin by a cascade of activating, conjugating and ligase enzymes, then recognised and degraded by the 26S proteasome; this provides selective, regulated control of cellular enzyme levels.

Mechanisms

An enzyme can lose activity without being destroyed, for example through denaturation, oxidation, or covalent modification at the active site, the last overlapping with irreversible inhibition (Kitz & Wilson, 1962). Distinct from this, regulated degradation removes the enzyme protein itself: in eukaryotes the principal route is the ubiquitin-proteasome system, in which a cascade of E1 activating, E2 conjugating, and E3 ligase enzymes attaches chains of ubiquitin to a target, marking it for recognition and hydrolysis by the 26S proteasome (Hershko & Ciechanover, 1998; Glickman & Ciechanover, 2002). Because the steady-state level of an enzyme reflects the balance of synthesis and degradation, controlling its half-life is a powerful means of regulating activity over minutes to hours (Cornish-Bowden, 2012).

Clinical relevance

Regulated protein degradation governs the abundance of many enzymes and regulatory proteins, and the ubiquitin-proteasome pathway is the target of established and emerging therapeutic strategies; understanding turnover clarifies why enzyme amount, not only activity, can be a control point (Glickman & Ciechanover, 2002). This entry describes the biology for reference and education and does not provide treatment advice.

History

While loss of enzyme activity through denaturation and covalent damage was long recognised, the molecular basis of regulated, selective protein degradation emerged from work on the ubiquitin system in the late twentieth century, reviewed comprehensively by Hershko and Ciechanover in 1998 (Hershko & Ciechanover, 1998) and by Glickman and Ciechanover in 2002 (Glickman & Ciechanover, 2002). This established degradation as a deliberate regulatory process rather than mere disposal.

Key figures

• Avram Hershko
• Aaron Ciechanover
• Michael H. Glickman
• Irwin B. Wilson

Seminal works

• hershko-ciechanover-1998
• glickman-ciechanover-2002

Frequently asked questions

What is the difference between enzyme inactivation and enzyme degradation?

Inactivation is loss of catalytic function while the protein may still be present (for example through denaturation or covalent modification); degradation is the actual breakdown of the enzyme protein, which reduces how much of it is in the cell.

How does the cell choose which enzymes to degrade?

Target proteins are selectively tagged with chains of ubiquitin by specific ligase enzymes, and this tag is recognised by the 26S proteasome, which then degrades the marked protein.